Antibiotic Developments
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Antimicrobial resistance a leading cause of global deaths, study shows
Antimicrobial resistance (AMR) has been found to be a leading cause of death worldwide in a study published in The Lancet. Read more
20 Jan 2022
BioVersys receives funding to develop new class of antibiotics to treat multidrug-resistant bacterial infections
Switzerland-based pharmaceutical company BioVersys has been awarded up to $4.35 million in funding to develop a new class of antibiotics for its work in developing a new class of antibiotics. Read more
7 Jun 2021
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Shutterstock
Acesion Pharma Closes Oversubscribed €45M Series B Financing Round
Acesion Pharma announces that it has successfully closed an oversubscribed €45M Series B financing round co-led by Canaan and Alpha Wave and with participation by the Global BioAccess Fund, as well as existing investor Novo Holdings. Read more
26 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
The Pistoia Alliance Lab of the Future Report Finds AI is Set to be Top Technology Investment for Life Sciences Companies
The Pistoia Alliance is releasing the results of a new global survey conducted in partnership with Open Pharma Research. The survey reveals that AI and Machine Learning will be the top tech investment over the next two years (60% of respondents). Read more
25 Sep 2023
Shutterstock
MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa
MC2 Therapeutics has acquired option rights from Regranion, LLC to exclusively license Regranion’s RGRN-305 for the treatment of all human diseases, incl, oral treatment of HS globally, excluding the greater China region. Read more
25 Sep 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Shutterstock
Biophytis and Skyepharma Sign a Partnership Agreement for Production of Sarconeos
Biophytis SA and Skyepharma announce the signature of a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19. Read more
25 Sep 2023
Shutterstock
Bora Collaborates with Sunway Biotech to Launch Global Nutraceuticals Offering
Bora Health has announced its collaboration with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organisation. Read more
25 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Riva-Europe
Suppliers of associated pharmaceutical machinery including tablet R&D tablet presses, capsule filling machines, fluid bed driers, granulators, tablet coating, blenders, roller compactors and powder handling equipment Read more
